StockData
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL) stock

LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.89+0.22 (+1.61%)

Close on Nov 18, 2026Market cap $340.38MP/E –Yield –

Lyell Immunopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lyell Immunopharma's market cap was $394.47M on Nov 11, 2026, against $463.05M a year earlier. Over the last 5 years it ranged from $128.95M to $1.86B, with a median of $463.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$394.47M-33.6%
2025Dec 31, 2025$593.87M+261.7%
2024Dec 31, 2024$164.20M-66.4%
2023Dec 29, 2023$488.63M-43.5%
2022Dec 30, 2022$864.86M-53.4%
2021Dec 31, 2021$1.86B–

More Lyell Immunopharma figures

See a number that looks wrong?